<SEC-DOCUMENT>0001339970-26-000023-index.html : 20260326
<SEC-HEADER>0001339970-26-000023.hdr.sgml : 20260326
<ACCEPTANCE-DATETIME>20260326161033
ACCESSION NUMBER:		0001339970-26-000023
CONFORMED SUBMISSION TYPE:	ARS
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20251231
FILED AS OF DATE:		20260326
DATE AS OF CHANGE:		20260326
EFFECTIVENESS DATE:		20260326

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			aTYR PHARMA INC
		CENTRAL INDEX KEY:			0001339970
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				203435077
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		ARS
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37378
		FILM NUMBER:		26798315

	BUSINESS ADDRESS:	
		STREET 1:		10240 SORRENTO VALLEY ROAD
		STREET 2:		SUITE 300
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		8587318389

	MAIL ADDRESS:	
		STREET 1:		10240 SORRENTO VALLEY ROAD
		STREET 2:		SUITE 300
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>ARS
<SEQUENCE>1
<FILENAME>2025annual_report.pdf
<DESCRIPTION>ARS
<TEXT>
Document 1 - file: 2025annual_report.pdf

</DOCUMENT>
</SEC-DOCUMENT>